메뉴 건너뛰기




Volumn 92, Issue 1, 2007, Pages 3-9

Approach to the patient: Approach to the patient with subclinical hyperthyroidism

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE; THYROTROPIN;

EID: 33846047562     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2472     Document Type: Article
Times cited : (63)

References (51)
  • 2
    • 0031767560 scopus 로고    scopus 로고
    • Iodine intake and the pattern of thyroid disorders: A comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark
    • Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR 1998 Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 83:765-769
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 765-769
    • Laurberg, P.1    Pedersen, K.M.2    Hreidarsson, A.3    Sigfusson, N.4    Iversen, E.5    Knudsen, P.R.6
  • 4
    • 0025940209 scopus 로고
    • Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression
    • Lewis GF, Alessi CA, Imperial JG, Refetoff S 1991 Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. J Clin Endocrinol Metab 73:843-849
    • (1991) J Clin Endocrinol Metab , vol.73 , pp. 843-849
    • Lewis, G.F.1    Alessi, C.A.2    Imperial, J.G.3    Refetoff, S.4
  • 8
    • 16244401455 scopus 로고    scopus 로고
    • A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only
    • Papi G, Pearce EN, Braverman LE, Betterle C, Roti E 2005 A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only. Am J Med 118:349-361
    • (2005) Am J Med , vol.118 , pp. 349-361
    • Papi, G.1    Pearce, E.N.2    Braverman, L.E.3    Betterle, C.4    Roti, E.5
  • 9
    • 0035864975 scopus 로고    scopus 로고
    • Thyroid hormone and the cardiovascular system
    • Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509
    • (2001) N Engl J Med , vol.344 , pp. 501-509
    • Klein, I.1    Ojamaa, K.2
  • 12
    • 0038021574 scopus 로고    scopus 로고
    • The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism on clinical and heart abnormalities
    • Sgarbi JA, Villaca F, Garbeline B, Villar HE, Romaldini JH 2003 The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism on clinical and heart abnormalities. J Clin Endocrinol Metab 88:1672-1677
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 1672-1677
    • Sgarbi, J.A.1    Villaca, F.2    Garbeline, B.3    Villar, H.E.4    Romaldini, J.H.5
  • 13
    • 0027056796 scopus 로고
    • Left ventricular hypertrophy and mortality-results from the Framingham Study
    • Kannel WB, Cobb J 1992 Left ventricular hypertrophy and mortality-results from the Framingham Study. Cardiology 81:291-298
    • (1992) Cardiology , vol.81 , pp. 291-298
    • Kannel, W.B.1    Cobb, J.2
  • 14
    • 25644437094 scopus 로고    scopus 로고
    • The evaluation of left ventricular hypertrophy in hypertensive patients with subclinical hyperthyroidism
    • Tamer I, Sargin M, Sargin H, Seker M, Babalik E, Tekce M, Yayla A 2005 The evaluation of left ventricular hypertrophy in hypertensive patients with subclinical hyperthyroidism. Endocr J 52:421-425
    • (2005) Endocr J , vol.52 , pp. 421-425
    • Tamer, I.1    Sargin, M.2    Sargin, H.3    Seker, M.4    Babalik, E.5    Tekce, M.6    Yayla, A.7
  • 17
    • 0029802333 scopus 로고    scopus 로고
    • Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine
    • Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, Salvatore M, Sacca L 1996 Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab 81:4224-4228
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 4224-4228
    • Biondi, B.1    Fazio, S.2    Cuocolo, A.3    Sabatini, D.4    Nicolai, E.5    Lombardi, G.6    Salvatore, M.7    Sacca, L.8
  • 18
    • 0034456381 scopus 로고    scopus 로고
    • Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: Effect of individual dose tailoring
    • Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, Pigliaru F, Mariotti S 2000 Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 85:159-164
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 159-164
    • Mercuro, G.1    Panzuto, M.G.2    Bina, A.3    Leo, M.4    Cabula, R.5    Petrini, L.6    Pigliaru, F.7    Mariotti, S.8
  • 19
    • 0025053854 scopus 로고
    • Is a more active attitude warranted in patients with subclinical thyrotoxicosis?
    • Tenerz A, Forberg R, Jansson R 1990 Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med 228:229-233
    • (1990) J Intern Med , vol.228 , pp. 229-233
    • Tenerz, A.1    Forberg, R.2    Jansson, R.3
  • 23
    • 0035883894 scopus 로고    scopus 로고
    • Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study
    • Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861-865
    • (2001) Lancet , vol.358 , pp. 861-865
    • Parle, J.V.1    Maisonneuve, P.2    Sheppard, M.C.3    Boyle, P.4    Franklyn, J.A.5
  • 26
    • 0019447236 scopus 로고
    • Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: Response to specific antithyroid therapy
    • Forfar JC, Feek CM, Miller HC, Toft AD 1981 Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: response to specific antithyroid therapy. Int J Cardiol 1:43-48
    • (1981) Int J Cardiol , vol.1 , pp. 43-48
    • Forfar, J.C.1    Feek, C.M.2    Miller, H.C.3    Toft, A.D.4
  • 27
    • 0034816710 scopus 로고    scopus 로고
    • Hemodynamic changes following treatment of subclinical and overt hyperthyroidism
    • Faber J, Wiinberg N, Schifter S, Mehlsen J 2001 Hemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol 145:391-396
    • (2001) Eur J Endocrinol , vol.145 , pp. 391-396
    • Faber, J.1    Wiinberg, N.2    Schifter, S.3    Mehlsen, J.4
  • 28
  • 29
    • 0027434963 scopus 로고
    • Bone mineral density in patients with endogenous subclinical hyperthyroidism: Is the thyroid status a risk factor for osteoporosis?
    • Foldes J, Tarjan G, Szathmary M, Varga F, Krasznai I, Horvath C 1993 Bone mineral density in patients with endogenous subclinical hyperthyroidism: is the thyroid status a risk factor for osteoporosis? Clin Endocrinol (Oxf) 39: 521-527
    • (1993) Clin Endocrinol (Oxf) , vol.39 , pp. 521-527
    • Foldes, J.1    Tarjan, G.2    Szathmary, M.3    Varga, F.4    Krasznai, I.5    Horvath, C.6
  • 30
    • 0026751673 scopus 로고
    • Peripheral bone density in women with untreated multinodular goitre
    • Mudde AH, Reijnders FJ, Kruseman AC 1992 Peripheral bone density in women with untreated multinodular goitre. Clin Endocrinol (Oxf) 37:35-39
    • (1992) Clin Endocrinol (Oxf) , vol.37 , pp. 35-39
    • Mudde, A.H.1    Reijnders, F.J.2    Kruseman, A.C.3
  • 31
    • 2442736253 scopus 로고    scopus 로고
    • Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women
    • Gurlek A, Gedik O 1999 Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Thyroid 9:539-543
    • (1999) Thyroid , vol.9 , pp. 539-543
    • Gurlek, A.1    Gedik, O.2
  • 33
    • 0035799398 scopus 로고    scopus 로고
    • Risk for the study of osteoporotic fractures. Risk for fracture in women with low serum levels of thyroid-stimulating hormone
    • Bauer DC, Ettinger B, Nevitt MC, Stone KL 2001 Risk for the study of osteoporotic fractures. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561-568
    • (2001) Ann Intern Med , vol.134 , pp. 561-568
    • Bauer, D.C.1    Ettinger, B.2    Nevitt, M.C.3    Stone, K.L.4
  • 34
    • 0028098795 scopus 로고
    • Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism
    • Mudde AH, Houben AJ, Nieuwenhuijzen Kruseman AC 1994 Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol (Oxf) 41:421-424
    • (1994) Clin Endocrinol (Oxf) , vol.41 , pp. 421-424
    • Mudde, A.H.1    Houben, A.J.2    Nieuwenhuijzen Kruseman, A.C.3
  • 35
    • 0031931052 scopus 로고    scopus 로고
    • Normalization of serum thyrotropin by mean of radioiodine treatment in subclinical hyperthyroidism. Effect of bone loss in postmenopausal women
    • Faber J, Jensen IW, Petersen L, Nygaard B, Hegedus L, Siersbaek-Nielsen K 1998 Normalization of serum thyrotropin by mean of radioiodine treatment in subclinical hyperthyroidism. Effect of bone loss in postmenopausal women. Clin Endocrinol (Oxf) 48:285-290
    • (1998) Clin Endocrinol (Oxf) , vol.48 , pp. 285-290
    • Faber, J.1    Jensen, I.W.2    Petersen, L.3    Nygaard, B.4    Hegedus, L.5    Siersbaek-Nielsen, K.6
  • 36
    • 0036022450 scopus 로고    scopus 로고
    • Is antithyroid treatment really relevant for young patients with subclinical hyperthyroidism?
    • Yonem O, Dokmetas HS, Aslan SM, Erselcan T 2002 Is antithyroid treatment really relevant for young patients with subclinical hyperthyroidism? Endocr J 49:307-314
    • (2002) Endocr J , vol.49 , pp. 307-314
    • Yonem, O.1    Dokmetas, H.S.2    Aslan, S.M.3    Erselcan, T.4
  • 38
    • 0025968327 scopus 로고
    • Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism
    • Stott DJ, McLellan AR, Finlayson J, Chu P, Alexander WD 1991 Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. Q J Med 78:77-84
    • (1991) Q J Med , vol.78 , pp. 77-84
    • Stott, D.J.1    McLellan, A.R.2    Finlayson, J.3    Chu, P.4    Alexander, W.D.5
  • 42
    • 15244342643 scopus 로고    scopus 로고
    • Subclinical hyperthyroidism in patients with nodular goiter represents a hypermetabolic state
    • Kvetny J 2005 Subclinical hyperthyroidism in patients with nodular goiter represents a hypermetabolic state. Exp Clin Endocrinol Diabetes 113:122-126
    • (2005) Exp Clin Endocrinol Diabetes , vol.113 , pp. 122-126
    • Kvetny, J.1
  • 44
    • 0026020685 scopus 로고
    • Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom
    • Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC 1991 Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 34:77-83
    • (1991) Clin Endocrinol (Oxf) , vol.34 , pp. 77-83
    • Parle, J.V.1    Franklyn, J.A.2    Cross, K.W.3    Jones, S.C.4    Sheppard, M.C.5
  • 46
    • 23644457979 scopus 로고    scopus 로고
    • Observations concerning the natural history of subclinical hyperthyroidism
    • Woeber KA 2005 Observations concerning the natural history of subclinical hyperthyroidism. Thyroid 15:687-691
    • (2005) Thyroid , vol.15 , pp. 687-691
    • Woeber, K.A.1
  • 49
    • 0036858505 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists 2002 American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8:457-469
    • American Association of Clinical Endocrinologists 2002 American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8:457-469
  • 50
    • 0029815604 scopus 로고    scopus 로고
    • Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism
    • Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN 1996 Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 313:539-544
    • (1996) BMJ , vol.313 , pp. 539-544
    • Vanderpump, M.P.1    Ahlquist, J.A.2    Franklyn, J.A.3    Clayton, R.N.4
  • 51
    • 0032527277 scopus 로고    scopus 로고
    • American College of Physicians 1998 Screening for thyroid disease. Ann Intern Med 129:141-143
    • American College of Physicians 1998 Screening for thyroid disease. Ann Intern Med 129:141-143


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.